BIS Healthcare Analysts in conversation with: Vijay Nimbarte Postdoctoral Researcher Max Planck Institute for Medical Research and Tehseen M. Dhorajiwala Scientific Curator Excelra
BIS Research provides premium market intelligence on deep technologies that have the potential to cause a high level of disruption in the market in the next few years. We excel in conducting market viability analysis for technologies that are still in the nascent stages of their lifecycle.
For each topic that we cover, BIS Research’s analysts interact with dozens of industry experts to scan, analyze, and predict the future of the concerned technology and its market. Our ‘Expert Insight’ series is one such initiative, where we make the industry insights available to senior executives in a short and quick to read format.
The global in-silico drug discovery market is undergoing a significant change regarding the advancements that have already taken place and are currently invading the market space. According to the expert interviews conducted for the study, most experts stated that the technological advancements in the field of computational biology have the potential to foster growth in the market. Rapid computational technological advancements in computational biology are driving the market growth of in-silico drug discovery.
BIS Healthcare Analysts in conversation with: Vijay Nimbarte Postdoctoral Researcher Max Planck Institute for Medical Research and Tehseen M. Dhorajiwala Scientific Curator Excelra
BIS Research provides premium market intelligence on deep technologies that have the potential to cause a high level of disruption in the market in the next few years. We excel in conducting market viability analysis for technologies that are still in the nascent stages of their lifecycle.
For each topic that we cover, BIS Research’s analysts interact with dozens of industry experts to scan, analyze, and predict the future of the concerned technology and its market. Our ‘Expert Insight’ series is one such initiative, where we make the industry insights available to senior executives in a short and quick to read format.
The global in-silico drug discovery market is undergoing a significant change regarding the advancements that have already taken place and are currently invading the market space. According to the expert interviews conducted for the study, most experts stated that the technological advancements in the field of computational biology have the potential to foster growth in the market. Rapid computational technological advancements in computational biology are driving the market growth of in-silico drug discovery.